{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:08:53Z","timestamp":1792667333793,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.niox.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T15:16:03Z","timestamp":1391786163000},"page":"66-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine"],"prefix":"10.1016","volume":"37","author":[{"given":"Mark A.","family":"Lovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt G.","family":"Wakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham E.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Y.","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas G.","family":"Gamero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B.","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Roscigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2014.02.001_b0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF03011970","article-title":"Inhaled nitric oxide: clinical applications, indications, and toxicology","volume":"44","author":"Troncy","year":"1997","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.niox.2014.02.001_b0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2014.02.001_b0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00000542-199303000-00005","article-title":"Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation","volume":"78","author":"Frostell","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.niox.2014.02.001_b0020","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.83.6.2038","article-title":"Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction","volume":"83","author":"Frostell","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2014.02.001_b0025","first-page":"H1921","article-title":"Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth","volume":"259","author":"Abman","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.niox.2014.02.001_b0030","doi-asserted-by":"crossref","first-page":"L450","DOI":"10.1152\/ajplung.00347.2004","article-title":"Inhaled no improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease","volume":"288","author":"McCurnin","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.niox.2014.02.001_b0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1164\/rccm.200503-384OC","article-title":"Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs","volume":"172","author":"Bland","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0040","doi-asserted-by":"crossref","first-page":"L964","DOI":"10.1152\/ajplung.00421.2002","article-title":"Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse","volume":"284","author":"Balasubramaniam","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.niox.2014.02.001_b0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0140-6736(92)92686-A","article-title":"Inhaled nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Roberts","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2014.02.001_b0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group","volume":"342","author":"Clark","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0140-6736(92)92687-B","article-title":"Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn","volume":"340","author":"Kinsella","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2014.02.001_b0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00003246-199803000-00043","article-title":"Placebo and inhaled nitric oxide mortality the same in ards clinical trial","volume":"26","author":"Dellinger","year":"1998","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s001340050982","article-title":"Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European study group of inhaled nitric oxide","volume":"25","author":"Lundin","year":"1999","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/ajrccm.149.2.7508323","article-title":"The biology of nitrogen oxides in the airways","volume":"149","author":"Gaston","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01720916","article-title":"Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 2. Pathophysiology","volume":"20","author":"Marshall","year":"1994","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.119.1.128","article-title":"Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension","volume":"119","author":"Cockrill","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.niox.2014.02.001_b0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1113\/expphysiol.1995.sp003892","article-title":"Development of the normal and hypertensive pulmonary vasculature","volume":"80","author":"Haworth","year":"1995","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.niox.2014.02.001_b0090","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/209706a0","article-title":"Kinetics of the reaction of nitric oxide with molecular oxygen","volume":"209","author":"Solc","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.niox.2014.02.001_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/189056a0","article-title":"Rates of the reactions of nitrogen atoms with oxygen and with nitric oxide","volume":"189","author":"Clyne","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.niox.2014.02.001_b0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/82.2.182","article-title":"Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances","volume":"82","author":"Schedin","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.niox.2014.02.001_b0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.niox.2011.04.006","article-title":"Use of ultra pure nitric oxide generated by the reduction of nitrogen dioxide to reverse pulmonary hypertension in hypoxemic swine","volume":"24","author":"Lovich","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2014.02.001_b0110","series-title":"Thermodynamics and An Introduction to Thermostatistics","author":"Callen","year":"1985"},{"key":"10.1016\/j.niox.2014.02.001_b0115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0120","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJM200006223422503","article-title":"Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue","volume":"342","author":"Hoeper","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0135","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJMct0904473","article-title":"Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension","volume":"361","author":"Archer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0140","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2014.02.001_b0145","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","article-title":"The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan hypertension investigators","volume":"338","author":"Krum","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2014.02.001_b0150","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.102.19.2434","article-title":"Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs","volume":"102","author":"Luscher","year":"2000","journal-title":"Circulation"},{"issue":"2003","key":"10.1016\/j.niox.2014.02.001_b0155","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF03019384","article-title":"Inhaled nitric oxide in 2003: a review of its mechanisms of action","volume":"50","author":"Wang","year":"2003","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.niox.2014.02.001_b0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cardiores.2007.04.014","article-title":"Inhaled no as a therapeutic agent","volume":"75","author":"Bloch","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2014.02.001_b0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.niox.2014.02.001_b0170","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.niox.2014.02.001_b0175","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2014.02.001_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0166-2236(91)90140-P","article-title":"Cgmp: the wayward child of the cyclic nucleotide family","volume":"14","author":"Goy","year":"1991","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.niox.2014.02.001_b0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI200524459","article-title":"No\/redox disequilibrium in the failing heart and cardiovascular system","volume":"115","author":"Hare","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2014.02.001_b0190","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.RES.0000100390.68771.CC","article-title":"Cyclic gmp-dependent protein kinases and the cardiovascular system: insights from genetically modified mice","volume":"93","author":"Feil","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2014.02.001_b0195","first-page":"357","article-title":"The biologic basis for inhaled nitric oxide","volume":"3","author":"Hurford","year":"1997","journal-title":"Respir. Care Clin. N. Am."},{"key":"10.1016\/j.niox.2014.02.001_b0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.febslet.2011.11.031","article-title":"Acetylation-dependent regulation of mitochondrial aldh2 activation by sirt3 mediates acute ethanol-induced enos activation","volume":"586","author":"Xue","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.niox.2014.02.001_b0205","doi-asserted-by":"crossref","first-page":"571067","DOI":"10.1155\/2012\/571067","article-title":"The chemical interplay between nitric oxide and mitochondrial cytochrome c oxidase: reactions, effectors and pathophysiology","volume":"2012","author":"Sarti","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.niox.2014.02.001_b0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2009.2842","article-title":"Interplay between calcium and reactive oxygen\/nitrogen species: an essential paradigm for vascular smooth muscle signaling","volume":"12","author":"Trebak","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.niox.2014.02.001_b0215","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.291.13.1603","article-title":"Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial","volume":"291","author":"Taylor","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.niox.2014.02.001_b0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0022-3468(96)90744-7","article-title":"Sustained pulmonary vasodilation after inhaled nitric oxide for hypoxic pulmonary hypertension in swine","volume":"31","author":"Emil","year":"1996","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.niox.2014.02.001_b0225","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0003-4975(96)00835-1","article-title":"Nitric oxide dose response during moderate and severe hypoxia in swine","volume":"63","author":"Emil","year":"1997","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.niox.2014.02.001_b0230","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1152\/jappl.1994.76.4.1794","article-title":"Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets","volume":"76","author":"Jacob","year":"1994","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.niox.2014.02.001_b0235","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s001340051027","article-title":"Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension","volume":"25","author":"Max","year":"1999","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0240","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1097\/00003246-200211000-00026","article-title":"Direct comparison of the effects of nebulized nitroprusside versus inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia-induced pulmonary hypertension in piglets","volume":"30","author":"Schreiber","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.niox.2014.02.001_b0245","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1378\/chest.109.6.1545","article-title":"Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests","volume":"109","author":"Channick","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.niox.2014.02.001_b0250","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1378\/chest.119.3.970","article-title":"One-year continuous inhaled nitric oxide for primary pulmonary hypertension","volume":"119","author":"Perez-Penate","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.niox.2014.02.001_b0255","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1053-2498(01)00304-7","article-title":"Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation","volume":"20","author":"Yung","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.niox.2014.02.001_b0260","doi-asserted-by":"crossref","first-page":"M418","DOI":"10.1097\/00002480-199703000-00147","article-title":"Hemodynamic effect of inhaled nitric oxide in dilated cardiomyopathy patients on lvad support","volume":"43","author":"Chang","year":"1997","journal-title":"ASAIO J."},{"key":"10.1016\/j.niox.2014.02.001_b0265","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.95.9.2250","article-title":"Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance","volume":"95","author":"Hare","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2014.02.001_b0270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(97)01307-6","article-title":"Randomized, double-blind trial of inhaled nitric oxide in lvad recipients with pulmonary hypertension","volume":"65","author":"Argenziano","year":"1998","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.niox.2014.02.001_b0275","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.niox.2014.02.001_b0280","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ajh.21832","article-title":"Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis","volume":"85","author":"Head","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.niox.2014.02.001_b0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev."},{"key":"10.1016\/j.niox.2014.02.001_b0290","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI2736","article-title":"Inhaled no as a viable antiadhesive therapy for ischemia\/reperfusion injury of distal microvascular beds","volume":"101","author":"Fox-Robichaud","year":"1998","journal-title":"J. Clin. Invest."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860314000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860314000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:52:28Z","timestamp":1565167948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860314000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":58,"alternative-id":["S1089860314000044"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2014.02.001","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}